-The Economic Times India will have a normal monsoon this year, says the Met office. This is good news, even though the forecast does not rule out some slack during the second half of the season. What matters finally is the distribution of rainfall across space and time rather than the aggregate percentages. However, a good monsoon is only one side of the story to have a strong farm sector. Reforms are...

-The United Nations A sustained rise in prices for raw natural resources and basic agricultural goods is defying long-standing patterns and appears to be hurting poor nations through rising food and fuel costs more than it is helping them through higher revenues for their commodities exports.   That was one of the findings of the Commodities and Development Report 2012, a study launched at the 13th session of the UN Conference on Trade...

-PTI Five American trade bodies, including USIBC, have joined hands to oppose efforts of the Indian government to further restrict participation of foreign companies in India's tobacco market. According to reports, the India's Commerce Ministry, on the request of Health Ministry, has proposed to put a complete FDI ban in the sector. Currently, foreign direct investment (FDI) is completely prohibited in manufacturing of tobacco and its substitutes, while such investments are allowed up...

Imagine you are a citizen racing across newspapers rapid fire. As you flip the pages you run across events like the Vedanta mining case, the Koodankulam nuclear controversy, the debate on poverty and reports about climate change. Each of these can be a life-threatening event and none of them have a life support system of knowledge which allows them to be debated in the open. The basic information comes from...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...